Robert Plenge News Today

Hopes are high that engineered immune cells, which are already in use to treat blood cancer, will halt the progression of a degenerative autoimmune disorder. Hopes are high that engineered immune cells, which are already in use to treat blood cancer, will halt the progression of a degenerative autoimmune disorder.

VantAI has inked a partnership with pharma giant Bristol Myers Squibb that hopes to use the body’s cellular waste disposal processes to treat disease.

BioPharma

In the last year, many Bristol-Myers Squibb Company ( NYSE:BMY ) insiders sold a substantial stake in the company which...

The FDA made history Thursday by approving Opill, a drug from the generic pharmaceutical manufacturer Perrigo.

Operator: Good morning. My name is Dennis, and I will be your conference operator today.

BMY earnings call for the period ending December 31, 2022.

GentiBio and BMS have signed a partnership agreement for developing new engineered Treg therapies for inflammatory bowel disease patients.

/PRNewswire/ -- GentiBio, Inc., an engineered regulatory T cells (Tregs) company, announced today that it has entered into a collaboration with Bristol Myers...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!